Ras Protein Mutation
Ras Protein Mutation - Related Videos
02:38
The Ras Gene
0 Views •
2021
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis. Ras is a superfamily...
02:38
The Ras Gene
0 Views •
2023
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis. Ras is a superfamily...
01:24
Small GTPases - Ras and Rho
0 Views •
2023
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides. Three regulatory proteins control their activity: Guanine nucleotide exchange factors or GEF, GTPase-activating proteins or GAPs, and Guanine nucleotide-dissociation inhibitors or GDIs. The GEF activates the GTPase by exchanging the bound-GDP with GTP. The GTPases’...
00:36
Viral Mutations
0 Views •
2019
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
02:27
Mutations
0 Views •
2020
Mutations are changes in the sequence of DNA. These changes can occur spontaneously during DNA replication or be induced by environmental factors. Mutations can be characterized in several ways: by whether and how they alter the amino acid sequence of the protein, by the scale of the DNA affected, and by whether they affect somatic or germline cells.Consequences of Point Mutations at the Molecular LevelMutations that affect a single nucleotide are called point mutations. When point mutations...
FAQs
The key change is persistence: an altered Ras protein may spend too much time in its GTP-bound active state because GTP hydrolysis is reduced or regulation by GTPase-activating proteins is impaired. Instead of responding appropriately to signaling controls, Ras can continue transmitting growth-related instructions. This abnormal timing and duration of signaling helps explain how a molecular change can influence cell behavior and disease.
GTPase-activating proteins normally contribute to Ras regulation by supporting the transition away from the active state. When a mutation impairs this regulatory relationship, Ras may not be efficiently returned to its GDP-bound inactive state. The consequence is not simply a change in protein structure; it is a prolonged signaling state that can promote inappropriate cellular growth and survival.
Persistently active Ras can signal through the RAF-MEK-ERK and PI3K-AKT pathways. These pathways connect the abnormal Ras state to cellular programs involving proliferation and survival, while Ras also participates in regulation of differentiation. Examining these downstream routes helps link a mutation at a signaling switch with broader biological effects and cancer-associated behavior.
Ras participates in regulation of cell growth, survival, and differentiation, so a mutation can disturb several aspects of cellular behavior simultaneously. Sustained pathway activity may affect whether cells continue growing, maintain survival programs, or alter differentiation. This broader influence helps explain why Ras mutations are studied as contributors to disease rather than as isolated abnormalities of cell division.
Mutation status provides a molecular feature that can be considered alongside the broader biology of a tumor. Because altered Ras signaling is associated with sustained activity in growth-related pathways and cancer development, identifying Ras mutations can support classification according to relevant molecular characteristics. This context helps researchers organize disease mechanisms and evaluate strategies aimed at tumors with particular signaling changes.
Their association with abnormal signaling and cancer development makes Ras mutations useful candidates for biomarker development. A mutation can provide information about the molecular features underlying a tumor and its signaling behavior. Studying these changes therefore supports efforts to connect genetic alterations with biologically meaningful disease categories and with research questions about targeted treatment design.
Studying the altered signaling state can inform the design of targeted inhibitors intended to address Ras-related signaling. Combination treatments are also relevant because the mutation can sustain signaling through routes such as RAF-MEK-ERK and PI3K-AKT. Considering these approaches together allows researchers to connect the mutation's molecular mechanism with strategies intended to counter its downstream effects.